当前位置:
X-MOL 学术
›
Resuscitation
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Drug therapy versus placebo or usual care for comatose survivors of cardiac arrest; a systematic review with meta-analysis
Resuscitation ( IF 6.5 ) Pub Date : 2024-11-14 , DOI: 10.1016/j.resuscitation.2024.110431 Peter J. McGuigan, Ellen Pauley, Glenn Eastwood, Leanne M.C. Hays, Janus C. Jakobsen, Marion Moseby-Knappe, Alistair D. Nichol, Niklas Nielsen, Markus B. Skrifvars, Bronagh Blackwood, Daniel F. McAuley
Resuscitation ( IF 6.5 ) Pub Date : 2024-11-14 , DOI: 10.1016/j.resuscitation.2024.110431 Peter J. McGuigan, Ellen Pauley, Glenn Eastwood, Leanne M.C. Hays, Janus C. Jakobsen, Marion Moseby-Knappe, Alistair D. Nichol, Niklas Nielsen, Markus B. Skrifvars, Bronagh Blackwood, Daniel F. McAuley
In Europe, approximately 291,000 cardiac arrests occur annually. Despite critical care therapy, hospital mortality remains high. This systematic review assessed whether, in comatose survivors of cardiac arrest, any drug therapy, compared to placebo or usual care, improves outcomes.
中文翻译:
药物治疗与安慰剂或心脏骤停昏迷幸存者的常规护理的比较;荟萃分析的系统评价
在欧洲,每年大约发生 291,000 例心脏骤停。尽管接受了重症监护治疗,但住院死亡率仍然很高。本系统评价评估了在心脏骤停的昏迷幸存者中,与安慰剂或常规护理相比,任何药物治疗是否能改善结局。
更新日期:2024-11-14
中文翻译:
药物治疗与安慰剂或心脏骤停昏迷幸存者的常规护理的比较;荟萃分析的系统评价
在欧洲,每年大约发生 291,000 例心脏骤停。尽管接受了重症监护治疗,但住院死亡率仍然很高。本系统评价评估了在心脏骤停的昏迷幸存者中,与安慰剂或常规护理相比,任何药物治疗是否能改善结局。